- $166.64m
- -$352.75m
- CNY1.70bn
- 89
- 96
- 77
- 99
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,440 | 2,052 | 3,922 | 1,980 | 1,702 |
Cost of Revenue | |||||
Gross Profit | 1,018 | 1,087 | 1,083 | 211 | 203 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,117 | 1,734 | 3,945 | 2,928 | 1,776 |
Operating Profit | 323 | 318 | -23.2 | -947 | -73.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 488 | 3,743 | 12.3 | -875 | 55.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | 405 | 3,373 | -8.54 | -1,111 | -37.9 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 391 | 3,370 | -8.54 | -1,111 | -37.9 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 391 | 3,370 | -8.54 | -1,111 | -37.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.38 | 11.1 | 0.414 | -3.34 | 0.31 |